Posted by zeugma on January 19, 2006, at 17:02:30
In reply to Atypical APs vs sedative antihistamines, posted by ed_uk on January 19, 2006, at 15:51:23
In the long-term, there need to be legal reforms to change the regulatory and commercial framework of incentives relating to drug development. These might include new forms of short-term re-patenting of old drugs.>>
Excellent idea, but it is a difficult thing to persuade anyone that drug development follows anything but an undeviating path to perfection. I exclude those who have taken the drugs that represent that undeviating path, but they tend not to be the type that get patent laws revised, through no fault of their own.
-z
poster:zeugma
thread:600777
URL: http://www.dr-bob.org/babble/20060115/msgs/600793.html